Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Reduced by Denali Advisors LLC

Denali Advisors LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 3,772 shares of the medical equipment provider’s stock after selling 77 shares during the period. Denali Advisors LLC’s holdings in Intuitive Surgical were worth $1,969,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Lake Street Advisors Group LLC lifted its stake in Intuitive Surgical by 6.0% during the fourth quarter. Lake Street Advisors Group LLC now owns 3,473 shares of the medical equipment provider’s stock valued at $1,813,000 after purchasing an additional 197 shares during the last quarter. JFG Wealth Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at $1,162,000. Kirtland Hills Capital Management LLC lifted its position in shares of Intuitive Surgical by 15.0% during the 4th quarter. Kirtland Hills Capital Management LLC now owns 1,125 shares of the medical equipment provider’s stock valued at $587,000 after acquiring an additional 147 shares during the last quarter. Longbow Finance SA bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $4,431,000. Finally, Amalgamated Bank grew its holdings in shares of Intuitive Surgical by 2.1% in the 4th quarter. Amalgamated Bank now owns 78,171 shares of the medical equipment provider’s stock worth $40,802,000 after acquiring an additional 1,592 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $580.93 on Thursday. The firm has a market cap of $206.92 billion, a price-to-earnings ratio of 90.63, a P/E/G ratio of 5.85 and a beta of 1.39. The stock has a 50-day simple moving average of $568.10 and a 200-day simple moving average of $527.65. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Wall Street Analyst Weigh In

Several brokerages have recently commented on ISRG. Jefferies Financial Group upped their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Piper Sandler reissued an “overweight” rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Citigroup boosted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Finally, Leerink Partners raised their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Activity at Intuitive Surgical

In other news, CFO Jamie Samath sold 188 shares of the stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $101,332.00. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,720,023. This represents a 2.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,240 shares of company stock valued at $3,529,040. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.